Aimee Adams, PharmD
Adjunct Assistant Professor, Pharmacy Practice and Science Department
UK College of Pharmacy
Ambulatory Care Specialist, Department of Internal Medicine
Director, Pharmacy Primary Care Practice Residency Program
UK Medical Center

Ann Amerson, PharmD
Professor Emeritus
Portfolio Review Coordinator
UK College of Pharmacy

Demetra Antimisiaris, PharmD, CGP, FASCP
Assistant Professor, Department of Family and Geriatric Medicine
University of Louisville

Ralph E. Bouvette, RPh, PhD, JD
Executive Director
APSC

Timothy M. Clifford, PharmD, BCPS
Transplant/Critical Care Specialist, Pharmacy Services
UK Medical Center
Adjunct Assistant Professor, Pharmacy Practice and Science Department
UK College of Pharmacy

Schely Cox
Pharmacists Mutual Insurance Company

Patricia R. Freeman, RPh, PhD
Associate Professor and Director, Professional Practice Programs, Department of Pharmacy Practice and Science
UK College of Pharmacy

Wendy Johnson, PharmD
Clinical Pharmacy Specialist
VMAC - Lexington

Robert J. Kuhn, PharmD
Professor, Pharmacy Practice and Science and Pediatrics
UK College of Pharmacy

J. Glee Lenoir, PharmD
Pharmacy Clinical Coordinator
Medical Center - Bowling Green

Jonathan Marquess, PharmD, CDE, CDM,
President, The Institute for Wellness and Education, Inc.
Woodstock, Georgia
Owner/Pharmacist
Lake Oconee Pharmacy, Eatonton, Georgia
Mckenzie Drugs, Lilburn, Georgia
Woodstock Pharmacy, Woodstock, Georgia
East Marietta Drugs, Marietta, Georgia

Robert P. Rapp, PharmD, FCCP
Professor, Pharmacy
UK College of Pharmacy
Professor, Surgery
UK College of Medicine
Manager, Clinical Services, Department of Pharmacy Services
UK Medical Center

Frank Romanelli, PharmD, MPH, BCPS
Assistant Dean for Education, Office of Education
Associate Professor, Pharmacy Practice and Science Department
UK College of Pharmacy
Associate Professor of Physician Assistant Studies (Joint Appointment) Division of Clinical Sciences
UK College of Allied Health
Clinical Specialist in HIV/AIDS
UK Medical Center

Alyson Schwartz, PharmD
Pharmacist
Medica Pharmacy and Hugh Hall, MD
Bardstown, Kentucky

Susan C. Sears
Partner
Dinsmore & Stohl, LLP- Lexington, KY

Dan Smoot, BS
Law Enforcement Director
Operation UNITE
Hazard, Kentucky

Sadhna G. True, Esquire
Dinsmore & Stohl LLP
Lexington, Kentucky

Kentucky Pharmacists Association supports the pharmacists and pharmacy technicians of Kentucky by providing programming on up-to-date topics faced in pharmacy practice.  Pharmacists and pharmacy technicians in practice in hospital/health system, community retail, consultant, long term care and insurance industries are the targeted audience for this convention.

Pharmacists in most cases are either the first place a patient goes to self medicate or the last place to receive care and prescriptions after seeing a physician.  Since patient centered care is paramount this convention targets disease states prevalent in Kentucky such as diabetes, cardiovascular disease and infectious diseases, as well as topics related to improving patient medication use and safety.  Quality improvement initiatives related to patient care, management and fraud, waste and abuse in reimbursement programs are addressed.  Updates on laws and new drugs are provided as well.

The educational needs for this program were derived from assessments carried out during the year as well as from previous conventions.  In addition topics were identified by practicing pharmacists.  The KPhA Convention Planning Committee consisting of pharmacists in hospital, community, long term care and academia reviewed the topics and selected the program.

Upon completion of this educational activity, particpants will be able to:

Pharmacists

• Identify risks in the prescription filling process
• List the steps in the Risk Management Process
• Implement risk management techniques to avoid medication errors
• Describe important elements of a professional  liability policy
• Discuss how Operation UNITE works to rid communities of illegal drug use through undercover narcotics investigations, treatment for substance abusers, support to families and friends of substance abusers, and public education about the dangers of using drugs
• Discuss UNITE’s goal to educate and activate individuals, by developing and empowering community coalitions, to no longer accept or tolerate the drug culture
• Describe common transplant medication regimens
• Describe common long-term complications after transplant.
• Review basic epidemiology, history, and pathophysiology regarding HIV infection
• Discuss current treatment options and guidelines for the management of HIV infection
• Discuss methods employed in reducing the risk of HIV transmission
• Discuss the current recommendations from FDA regarding the use of cough and cold preparations in children
• Describe patient specific guidelines for recommendations of these products
• Define “syllabus” and describe its use
• List and describe the usual components of information included in a syllabus
• Describe how a syllabus helps both the preceptor and the student
• Develop a process for designing and evaluating potential learning activities
• Discuss ideas to facilitate student learning and management of the rotation experience
• Counsel a patient regarding appropriate warfarin dosing, diet/drug interactions, adverse effects, and need for regular lab monitoring
• Monitor a patient’s warfarin therapy and make appropriate dosage adjustments based on clinical findings and laboratory results
• Differentiate between the pharmacologic options for prevention and treatment of thromboembolism
• Discuss opportunities for pharmacists to improve the safety of anticoagulation administration in the healthcare facility
• Describe the role of the pharmacist in anticoagulation management in different practice settings
• Review the impact of Diabetes
• List the American Diabetes Association (ADA) recommended goals for glycemic control, blood pressure, and lipid management
• Discuss 10 Key Interventions that will make a difference for patients with diabetes
• Define the benefits of targeted glycemic control
• Evaluate current blood glucose technology
• Define polypharmcy as a co-morbidity
• List the causes of polypharmacy
• Recognize why polypharmacy is a hazard for elderly patients
• Describe the Beers Criteria
• Discuss the pharmacists’ role to help combat polypharmcy
• Practice sorting through a classic polypharmcy case in an elderly patient
• Identify the governmental agencies with enforcement authority for eliminating fraud, waste and abuse in the Medicare and Medicaid programs
• Describe each agency’s scope of authority
• Discuss a pharmacist’s obligations in seeking reimbursement from Medicare and Medicaid
• Identify factual scenarios that encourage suspicions of fraudulent activity
• Establish business practices to prevent findings of fraud
• Respond promptly and appropriately to potential sexual or other workplace harassment situations
• Identify practical tips that will aid in recognizing/identifying issues that often give rise to employee legal claims
• Discuss particular employment issues related to the pharmacy workplace “culture”
• Differentiate community-acquired MRSA from healthcare-associated MRSA
• Describe the role of the mecA gene relative to the mechanism of resistance in isolates of MRSA
• Describe therapeutic options to treat both superficial and invasive infections caused by MSA
• Discuss bills introduced and legislation passed by the Kentucky General Assembly in the 2008 Regular Session affecting the practice of pharmacy and implement appropriate changes into practice
• Describe new and recent changes to existing Kentucky pharmacy laws and implement appropriate changes into practice
• Identify new molecular and biological entities, with the exception of diagnostic compounds, that entered the US drug market from June 2007-May 2008
• Describe each agent’s mechanism of action, dosage, adverse reactions, contraindications, and drug interaction profile
• Compare them with other agents used for the same indications
• List special patient instruction and monitoring parameters for each of these agents

Technicians

• Identify risks in the prescription filling process
• List the steps in the Risk Management Process
• Implement risk management techniques to avoid medication errors
• Describe important elements of a professional  liability policy
• Discuss how Operation UNITE works to rid communities of illegal drug use through undercover narcotics investigations, treatment for substance abusers, support to families and friends of substance abusers, and public education about the dangers of using drugs
• Discuss UNITE’s goal to educate and activate individuals, by developing and empowering community coalitions, to no longer accept or tolerate the drug culture
• Define polypharmcy as a co-morbidity
• List the causes of polypharmacy
• Recognize why polypharmacy is a hazard for elderly patients
• Describe the Beers Criteria
• Practice sorting through a classic polypharmcy case in an elderly patient
• Discuss the technicians’ role to help combat polypharmcy
• Identify the governmental agencies with enforcement authority for eliminating fraud, waste and abuse in the Medicare and Medicaid programs
• Describe each agency’s scope of authority
• Identify factual scenarios that encourage suspicions of fraudulent activity
• Apply established business practices to prevent findings of fraud
• Discuss particular employment issues related to the pharmacy workplace “culture”
• Identify potential sexual or other workplace harassment situations
• Discuss the role of triple antibiotic ointment as a preventative measure for skin infections caused by MRSA
• List the most common types of infections caused by MRSA
• Describe the role of incision and drainage in skin infections caused by MRSA
• Discuss bills introduced and legislation passed by the Kentucky General Assembly in the 2008 Regular Session affecting the practice of pharmacy and implement appropriate changes into practice
• Describe new and recent changes to existing Kentucky pharmacy laws and implement appropriate changes into practice
• Identify new medications that entered the US drug market from June 2007– May 2008
• Identify the brand name and manufacturer of each agent
• Identify the therapeutic class of each agent
• Describe the storage and handling conditions for each agent

Pharmacy Technician
The University of Kentucky College of Pharmacy is approved by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity has been assigned ACPE # 022-999-08-084-L03-T, 022-999-08-072-L03-T, 022-999-08-004-L01-T, 022-999-08-079-L04-T, 022-999-08-080-L04-T, 022-999-08-081-L01-T, 022-999-08-082-L03-T, 022-999-08-083-L01-T and will award 10 contact hours (1 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers. Statements of credit will indicate hours and CEUs based on successful completion of a posttest (score 70% or higher) and will be issued upon completion of the activity. The college complies with the Criteria for Quality for continuing education programming.

To register, click on http://www.kentuckypharmacists.com/user/130thRegistrationForm.pdf.

Full Registration by June 5
Member - $175
Non-member - $350
Technician/Resident - $75
Student - $15

Full Registration after June 5
Member - $225
Non-member - $400
Technician/Resident - $100
Student - $25

Single Day Registration by June 5
Member - $90
Non-member - $175
Technician/Resident - $45
Student - $10

Single Day Registration after June 5
Member - $115
Non-member - $200
Technician/Resident - $70
Student - $20

Meal Events 
Welcome Luncheon - additional guest $30
Kroger Luncheon - additional guest $30
Ray Wirth Awards Banquet - additional guest $45
UK Alumni Luncheon - additional guest $30

Exhibitors
Acorda Therapeutics
Adams Respiratory Therapeutics
American Pharmacy Cooperative Inc. (APCI)
American Pharmacy Services Corporation (APSC)
AmerisourceBergen
Apotex Corporation
Blu Pharmaceuticals
Cardinal Health
Carmel Pharma, Incorporated
CVS Caremark
Dr. Comfort
EPIC Pharmacy
HCC/FDS, Inc.
Health Care Excel
J & J Lifescan
Kentucky Cabinet for Health & Family Services
Kentucky Pharmacists Political Advocacy Council
Matrix Distributors, Inc.
McKesson Corporation
Miami-Luken, Inc.
Pharmacists Mutual
QS/1
Rite-Aid Pharmacy
Samuels Products
Smith Drug Company
Walgreens

Sponsors
American Pharmacy Corporation Incorporated (APCI)
American Pharmacy Services Corporation (APSC)
EPIC Pharmacy
Kentucky Pharmacists Political Advocacy Council
Sullivan University College of Pharmacy

For overnight accommodations, contact the Crowne Plaza Hotel Lexington at 859.255.4281 and reference Group Code KPA for the special rate of $99.00.

Cut-off for this rate is May 19, 2008.

Any request for refunds must be submitted in writing to the KPhA Office which should include the reason for canceling. All refunds will be reviewed by the KPhA Executive Committee on an individual basis. Requests for refunds must be received prior to June 13, 2008.

The KPhA and the Colleges of Pharmacy and Medicine Continuing Education Office reserves the right to cancel or make substitutions in this activity. A full refund will be issued if circumstances warrant cancellation of the conference.